title: Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: a 14-year study.
abstract: The objective of this study was to determine the relationship between clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and antimicrobial consumption in hospitalized patients over a 14-year period. The study was retrospectively conducted between January 1995 and December 2008 at Juntendo University Hospital, Tokyo, Japan, a 1,020-bed tertiary-care teaching hospital. The incidence of MRSA isolates was examined using clinical specimens presented to the microbiology laboratory in the hospital. Antimicrobial consumption through intravenous injection was calculated in terms of the number of defined daily doses per 100 bed-days. The correlation between the incidence of MRSA isolates and antimicrobial consumption was determined employing a multiple stepwise regression analysis. A total of 109,946 bacterial isolates were consecutively collected over the 14-year period, and, of these, 13,872 (64% of S. aureus strains excluding coagulase-negative staphylococci) were MRSA strains. The longitudinal observation showed that the number and rate of MRSA isolates marginally decreased. The rate of MRSA isolates among S. aureus strains in 1995 was 68.5%, whereas that in 2008 was 53.8%. Consumption of cephalosporins decreased. Among carbapenems, the rate of imipenem (IPM) consumption decreased, whereas that of meropenem increased. A multiple stepwise regression analysis revealed that the antimicrobial consumption of cefmetazole, cefotiam, and IPM was positively correlated with the incidence of MRSA isolates. The use of β-lactam antimicrobials may contribute to the development of MRSA strains.
authors.affiliation: Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
authors.forename: Ayako
authors.initials: A
authors.lastname: Nakamura
authors.forename: Kazunori
authors.initials: K
authors.lastname: Miyake
authors.forename: Shigeki
authors.initials: S
authors.lastname: Misawa
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Kuno
authors.forename: Takashi
authors.initials: T
authors.lastname: Horii
authors.forename: Satoshi
authors.initials: S
authors.lastname: Hori
authors.forename: Shigemi
authors.initials: S
authors.lastname: Kondo
authors.forename: Yoko
authors.initials: Y
authors.lastname: Tabe
authors.forename: Akimichi
authors.initials: A
authors.lastname: Ohsaka
mesh_terms: D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*; D010641:Phenotype; D012044:Regression Analysis; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology*; D047090:beta-Lactams / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams